Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Drug Discov Today. 2017 Mar 21;22(7):1077–1083. doi: 10.1016/j.drudis.2017.03.006

Figure 4.

Figure 4

Impact of industry consolidation. (a) The number of private sector organizations that have gained an approval for at least one imaging new molecular entity (NME) and which are still active in new NME research and development is shown on a decade-by-decade basis. Please note that the red bars on the negative axis reflect the impact of industry consolidation or bankruptcies that led to the loss of an organization involved in research and development. (b). The net number of private sector organizations with active NME research and development programs is shown over time.